Areas of Focus
- Research on signaling pathways and molecular mechanisms of liver cancer occurrence and development
- Molecular typing and mechanism of drug resistance in targeted therapy for gastrointestinal tumors
Academic Background & Achievements
- 1998.9-2002.7 Bachelor: South China Agricultural University, Biotechnology
- 2005.9-2008.7 Master: First Military Medical University, Immunology
- 2008.9-2012.7 Doctorate: Southern Medical University, Immunology
Publications
- RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway., Wang Suihai, Wang Xiaobo, Gao Yanjun, Peng Yingxia, Dong Ninging, Xie Qian, Zhang Xian, Wu Yingsong, Li Ming, Ji-liang, 2019
- RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway., Wang Suihai, Huang Xiang, Li Yue, Lao Haimiao, Zhang Ying, Dong Huimin, Xu Weiwen, Li Ji-liang, Li Ming, 2011
- Tspan5 is an independent favourable prognostic factor and suppresses tumour growth in gastric cancer., He Peirong, Wang Suihai, Zhang Xuefeng, Gao Yanjun, Niu Wenbo, Dong Ningning, Shi Xiangyi, Geng Yan, Ma Qiang, Li Ming, Jiang Bo, Li Ji-liang, 2016
- MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis., Yue Li, You Li, Yao Chen, Qian Xie, Ningning Dong, Yanjun Gao, Huan Deng, Chunhua Lu, Suihai Wang, 2017
- MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription., Li Yue, Tsang CK, Wang Suihai, Li xiaoxing, Yang Yang, Fu Liwu, Huang Wenlin, Li Ming, Wang HuiYun, Zheng XF, 2016
